Bernstein cuts Hershey stock price target on muted Q2 outlook By Investing.com

Hershey beat first-quarter 2026 expectations with EPS of $2.35 versus $2.04 consensus and revenue of $3.1 billion versus $3.02 billion, but analysts remain cautious on near-term growth. Bernstein SocGen cut its price target to $208 from $250, while TD Cowen raised its target to $210 on confidence in 2026 guidance and a return to volume growth in 2027. Management reiterated full-year guidance, flagged flattish organic sales growth in Q2, and said gross margin should expand about 300 bps next quarter and 500 bps in the second half.

Analysis

HSY is in a classic “good quarter, softer setup” tape: the market is likely to keep rewarding visible execution in the near term while discounting the more important volume/mix debate into the back half. The key second-order effect is that a margin-led beat with flattish organic sales can temporarily mask share pressure, but shelf resets and premium innovation should help defend facings before the next holiday window. That makes the next 1-2 quarters more about confirmation than acceleration.

The broader read-through is more important for the rest of packaged food: if Hershey is still seeing competitive merchandising intensity and only modest demand elasticity despite heavy promotional noise, it implies category winners will be the names with the strongest distributor leverage and fastest innovation cadence. Conversely, players relying on broad-based price realization without meaningful news flow could see trade budgets rise faster than revenue. In other words, the earnings quality bar is shifting from price/margin to share retention.

The contrarian angle is that the market may be underestimating how much of the bullish narrative is already in the valuation. A premium multiple on a defensive staple is hard to justify if volume growth remains absent and gross-margin expansion is largely cost/timing-driven rather than structural. The real catalyst for a rerate is not another beat; it is evidence that new product launches and channel resets are translating into sustained takeaway over the next two reporting cycles. Until then, upside is probably capped unless management converts the second-half launch pipeline into measurable market-share gains.

For positioning, the setup favors owning the name on dips around event-driven weakness, but not aggressively chasing strength. The asymmetry is better expressed through relative-value trades versus slower-moving staples rather than an outright long with stretched expectations. If the back-half launch and shelf-space gains fail to show up in scanner data by late summer, the multiple should compress quickly.

Key Decisions for Investors

• Hold a tactical long HSY into the next 4-8 weeks only on post-earnings or analyst-downgrade pullbacks; target a 6-8% rebound, but use a tight stop if channel checks fail to confirm shelf-space gains.
• Fade the valuation premium via a pair trade: long a lower-multiple defensive consumer name with cleaner volume momentum vs short HSY for 1-3 months; the setup is for multiple compression if guidance remains unchanged and growth stays flat.
• Buy HSY downside protection for the late-summer/early-fall window (2-4 months out) to hedge the risk that second-half premium launches disappoint; this is the highest convexity way to express skepticism while preserving upside from a rerating.
• For investors already long staples, rotate incremental capital away from names with stagnant volumes and into companies with visible innovation or channel expansion, as the market is likely to reward share gains more than margin defense over the next two quarters.